FDA Advisory Committee Recommends Approval of Aridol
23rd
Nov 09
Release Date: 23/11/2009 12:00am
Pharmaxis today announced that an advisory committee of the U.S. Food and Drug Administration (FDA) has voted to recommend the approval of Aridolâ„¢ (mannitol bronchial challenge test) for use as a bronchial test to assess bronchial hyperresponsiveness to aid in diagnosing patients who have symptoms of asthma or symptoms that are suggestive of asthma.
Â
Categories: News and Media